Internal Medicine, Rheumatology · Huntington Beach, CA
NPI
1679597033
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
17822 Beach Blvd, 442
Huntington Beach, CA, 92647
Phone (714) 549-4081
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,154
2,023 services
Medicare patients, 2024
71
Average age 75
Drug cost, 2024
$5.9M
2,794 prescriptions
Company payments, 2025
$30.35
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lalitha Ananth was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,720 times for 24 patients. In total Lalitha Ananth billed 2,023 services in 13 codes, and Medicare paid $6,154.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,720 | 24 | $0.09 | $160 |
| 96372 Injection Administration | Office | 124 | 61 | $9.88 | $1,225 |
| J0897 Injection, denosumab, 1 mg | Office | 54 | 44 | $0.01 | $0.38 |
| 20610 Joint Injection | Office | 35 | 19 | $57.87 | $2,026 |
| 20600 Joint Injection | Office | 28 | 14 | $39.50 | $1,106 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 28 | 17 | $3.41 | $95.6 |
By year: 2022 $8,649 for 404 services; 2023 $9,100 for 329 services; 2024 $6,154 for 2,023 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lalitha Ananth prescribed most often to Medicare patients was Xeljanz Xr (Tofacitinib Citrate), with 208 prescriptions and refills. In total Lalitha Ananth wrote 2,794 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xeljanz Xr Tofacitinib Citrate | 208 | 218 | 33 | $1.2M |
| Rinvoq Upadacitinib | 193 | 195 | 37 | $1.2M |
| Diclofenac Sodium Generic | 183 | 187 | 66 | $67K |
| Lidocaine Generic | 175 | 189 | 43 | $22K |
| Prolia Denosumab | 125 | 750 | 85 | $202K |
| Hydroxychloroquine Sulfate Generic | 120 | 166 | 30 | $3,337 |
| Methotrexate Methotrexate Sodium | 88 | 130 | 28 | $1,406 |
| Famotidine Generic | 80 | 138 | 36 | $552 |
| Gabapentin Generic | 77 | 81 | 18 | $534 |
| Enbrel Sureclick Etanercept | 77 | 79 | 14 | $556K |
| Prednisone Generic | 77 | 88 | 29 | $379 |
| Tramadol Hcl Generic | 75 | 76 | 21 | $525 |
| Trazodone Hcl Generic | 71 | 98 | 16 | $253 |
| Otezla Apremilast | 69 | 69 | 14 | $322K |
| Xeljanz Tofacitinib Citrate | 67 | 85 | 12 | $361K |
Brand drugs: - claims; generic drugs: 1,622 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lalitha Ananth $30.35 ($30.35 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $30.35.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $30.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.